In other words, methylation status of the Axin gene might serve as a pathologic marker in predicting radiosensitivity for lung cancer patients, with a possible increase in radiosensitivity in lung cancers with a hypermethylated Axin gene and a possible decreased in radiosensitivity in those with an unmethylated Axin gene. The gene discussed is AXIN1; the disease is lung carcinoma.